Fred F. Poordad

Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.

A. Sanyal, E. Bortey, W. Forbes, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Randomised clinical trial: rifaximin improves health‐related quality of life in cirrhotic patients with hepatic encephalopathy – a double‐blind placebo‐controlled study

A. Sanyal, Z. Younossi, E. Bortey, 2011, Alimentary pharmacology & therapeutics.